| Business Name: |
Airway Therapeutics Inc |
| Contact Person: |
Charles C Mcosker |
| Address: |
9601 Medical Center Drive, Rockville, Maryland 20850 |
| Phone Number: |
(954) 776-4500 |
| Annual Revenue (USD): |
$50.000 to $99.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Research and Development Laboratories |
| SIC Code: |
8731 |
| NAICS Code: |
541712 |
| Share This Business: |
|
| Related Businesses: |
20 20 Genesystems Inc - Rockville, MD 20850
Thielen Scientific LLC - Rockville, MD 20850
Keygene Inc - Rockville, MD 20850
Leidos Inc - Rockville, MD 20850
Us Virgene - Rockville, MD 20850
Ascentgene Inc - Rockville, MD 20850
Rapid Laboratories Inc - Rockville, MD 20850
Technology Digest Inc - Rockville, MD 20850
Keyway Technologies Inc - Rockville, MD 20850
Chan Test Corp - Rockville, MD 20850
Odera Technologies - Rockville, MD 20850
Lisa H Xie - Rockville, MD 20850
Delsoft Technologies - Rockville, MD 20850
Plantvax Inc - Rockville, MD 20850
Knewco Inc - Rockville, MD 20850
Drs Technologies - Rockville, MD 20850
Benevir Biopharm Inc - Rockville, MD 20850
Thelma Galkin - Rockville, MD 20850
Antex Biologics Inc - Rockville, MD 20850
Bioqual Inc - Rockville, MD 20850
|
The company Airway Therapeutics Inc provides B2B services in the form of Research and Development Laboratories from its single location in Maryland.
1 to 4 employees work for Airway Therapeutics Inc, and the business now earns $50.000 to $99.999 per annum.
Airway Therapeutics Inc was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Airway Therapeutics Inc, please call Charles C Mcosker with the phone number (954) 776-4500 or visit its single location at 9601 Medical Center Drive in Rockville, Maryland 20850.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.